EMMAUS LIFE SCIENCES, INC.

Profile

Company Names

EMMAUS LIFE SCIENCES, INC.
AFH ACQUISITION IV, INC.

Addresses

21250 HAWTHORNE BLVD., SUITE 800, TORRANCE, CA 90503

21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA 90503

20725 S. WESTERN AVE., SUITE 136, TORRANCE, CA 90501

9595 WILSHIRE BLVD., SUITE 700, BEVERLY HILLS, CA 90212

Phone Numbers

310-214-0065
(310) 214-0065
(310) 492-9898

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, OTHER

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$48,764,832.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2019-02-12 
$2,585,000.00 
INDEFINITE 
INDEFINITE 
Equity 
7
2018-10-22 
$12,200,000.00 
$12,200,000.00 
$0.00 
Debt 
6
2016-09-29 
$20,000,000.00 
$20,000,000.00 
$0.00 
Equity 
5
2016-01-13 
$1,700,000.00 
$40,000,000.00 
$38,300,000.00 
Equity 
4
2013-09-11 
$7,551,253.00 
$7,551,253.00 
$0.00 
Equity 
3
2011-06-29 
$3,715,079.00 
$3,715,079.00 
$0.00 
Debt 
2
2011-05-03 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2011-03-25 
$1,013,500.00 
$1,200,000.00 
$186,500.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TIMOTHY 
 
BRASEL 
EXECUTIVE OFFICER, DIRECTOR
AFH ACQUISITION IV, INC.   |  SPLASH BEVERAGE GROUP, INC.   |  PRIME TIME LIVE, INC.
MAURICE 
 
DEWALD 
DIRECTOR
EMMAUS LIFE SCIENCES, INC.   |  CNS RESPONSE, INC.
MAURICE 
J. 
DEWALD 
DIRECTOR
HEALTHCARE TRUST OF AMERICA HOLDINGS, LP   |  TARGETED MEDICAL PHARMA, INC.   |  EMMAUS LIFE SCIENCES, INC.
ROBERT 
 
DICKEY 
DIRECTOR
CASABLANCA MINING LTD.   |  SANUTHERA, INC.   |  TIMERAZOR INC.   |  PISTON HOLDINGS L.P.   |  EMMAUS LIFE SCIENCES, INC.   |  EMMAUS LIFE SCIENCES, INC.   |  BLINKTBI, INC.
TRACEY 
C. 
DOI 
DIRECTOR
EMMAUS LIFE SCIENCES, INC.
AMIR 
 
HESHMATPOUR 
DIRECTOR
EMMAUS LIFE SCIENCES, INC.   |  SHUTTLE PHARMACEUTICALS HOLDINGS, INC.   |  NEONC TECHNOLOGIES HOLDINGS, INC.
AMIR 
F. 
HESHMATPOUR 
EXECUTIVE OFFICER, DIRECTOR
AFH ACQUISITION IV, INC.   |  AFH ACQUISITION VII, INC.   |  NEONC TECHNOLOGIES HOLDINGS, INC.
KURT 
 
KRUGER 
EXECUTIVE OFFICER
EMMAUS LIFE SCIENCES, INC.
JON 
 
KUWAHARA 
DIRECTOR
EMMAUS LIFE SCIENCES, INC.   |  NOVUS THERAPEUTICS, INC.
WILLIS 
 
LEE 
EXECUTIVE OFFICER, DIRECTOR
EMMAUS LIFE SCIENCES, INC.   |  EMMAUS LIFE SCIENCES, INC.
WILLIS 
C 
LEE 
EXECUTIVE OFFICER, DIRECTOR
EMMAUS LIFE SCIENCES, INC.
WILLIS 
C. 
LEE 
EXECUTIVE OFFICER, DIRECTOR
EMMAUS MEDICAL INC   |  EMMAUS LIFE SCIENCES, INC.
PETER 
 
LUDLUM 
EXECUTIVE OFFICER
ENERGY + POWER SOLUTIONS, INC.   |  EMMAUS LIFE SCIENCES, INC.   |  PULMATRIX, INC.
PETER 
B 
LUDLUM 
EXECUTIVE OFFICER
EMMAUS LIFE SCIENCES, INC.
HENRY 
A. 
MCKINNELL 
DIRECTOR
EMMAUS LIFE SCIENCES, INC.
YASUSHI 
 
NAGASAKI 
EXECUTIVE OFFICER
EMMAUS MEDICAL INC   |  EMMAUS LIFE SCIENCES, INC.   |  EMMAUS LIFE SCIENCES, INC.
YUTAKA 
 
NIIHARA 
EXECUTIVE OFFICER, DIRECTOR
EMMAUS MEDICAL INC   |  EMMAUS LIFE SCIENCES, INC.   |  EMMAUS LIFE SCIENCES, INC.
MASAHARU 
 
OSATO 
DIRECTOR
EMMAUS LIFE SCIENCES, INC.   |  EMMAUS LIFE SCIENCES, INC.
ALFRED 
E. 
OSBORNE JR. 
DIRECTOR
EMMAUS LIFE SCIENCES, INC.
LAN 
 
TRAN 
EXECUTIVE OFFICER
EMMAUS LIFE SCIENCES, INC.
LAN 
T 
TRAN 
EXECUTIVE OFFICER
EMMAUS LIFE SCIENCES, INC.
LAN 
T. 
TRAN 
EXECUTIVE OFFICER
EMMAUS MEDICAL INC   |  EMMAUS LIFE SCIENCES, INC.
WEI PEU 
 
ZEN 
DIRECTOR
EMMAUS LIFE SCIENCES, INC.
IAN 
 
ZWICKER 
DIRECTOR
EMMAUS LIFE SCIENCES, INC.   |  EMMAUS LIFE SCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-04-01
D
Link
PHARMACEUTICALS 
BLANK CHECKS [6770] 
$5,000,001 - $25,000,000 
Equity 
2019-02-12 
2018-11-01
D
Link
PHARMACEUTICALS 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Debt 
2018-10-22 
2016-10-14
D
Link
PHARMACEUTICALS 
BLANK CHECKS [6770] 
$1 - $1,000,000 
Equity 
2016-09-29 
2016-01-20
D
Link
PHARMACEUTICALS 
BLANK CHECKS [6770] 
$1 - $1,000,000 
Equity 
2016-01-13 
2013-10-02
D/A
Link
PHARMACEUTICALS 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2013-09-11 
2013-09-24
D
Link
PHARMACEUTICALS 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2013-09-11 
2011-10-18
D
Link
PHARMACEUTICALS 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Debt 
2011-06-29 
2011-09-26
D
Link
PHARMACEUTICALS 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2011-05-03 
2011-04-04
D
Link
OTHER 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2011-03-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
N/A
NONE
NONE
NONE
T.R. WINSTON + COMPANY, LLC
10571
MORE THAN FIVE (5) ASSOCIATED PERSONS
NONE
T.R. WINSTON + COMPANY LLC
10571